Rexahn Pharmaceuticals, Inc. (REXN)

[Spideyboy]

Well I was just posting as something is finally happening. One could say this is coming half a year late on their 2Q/3Q 2017 guidance for the data read out.

While it will be good to see something positive I'm not expecting much to happen for the PPS. I mean we are still not close to making revenue, no clear partnerships being announced, (hopefully good phase II data can help with this), and as far as biotech investing is concerned, generally no-one really cares about Phase II data in a pre-revenue company, unless the phase II really knocks it out of the park. They'll wait out till at least close to phase III data and get in then, as in the meantime it will still mean cash burn and likely dilution till the proof that the FDA will allow to sell the product.

But still looking forward to any good news they can give and hoping for more soon as they have other missed guidance which hopefully like this needed just a little extra time.